Neuroscience Drug Discovery and Disease Modelling
Neurological drug development often fails because early models do not reproduce the human biology that drives disease or measure outcomes …
Neurological drug development often fails because early models do not reproduce the human biology that drives disease or measure outcomes …
Non-human primate biological materials are used in research because of their physiological, immunological and genetic similarities to humans. They can …
Vaccine development requires alignment between antigen design, delivery platform, formulation and the immune response needed for protection or therapeutic activity. …
The development of effective cancer immunotherapies requires a clear understanding of tumour biology, immune-cell function and the mechanisms that limit …
Conventional monolayer cultures remain useful for many assays, but they cannot fully reproduce the spatial organisation, cellular diversity and local …
Stem cell models offer a renewable and biologically relevant source of human cells for studying disease mechanisms, evaluating drug candidates …
A gene therapy programme depends on more than the therapeutic sequence alone. Vector architecture, tissue tropism, expression control, delivery efficiency …
Glycosylation can influence the folding, stability, solubility, receptor interactions, serum persistence and immune effector functions of a therapeutic protein. It …
The performance of an mRNA therapeutic depends on both the RNA molecule and the delivery system. Sequence architecture affects stability …
Creative Biolabs provides integrated antibody discovery and development services to support pharmaceutical, biotechnology and academic research programmes. Our capabilities span …
Applications in Flow Cytometry, Cell Sorting, Target Validation, and Therapeutic Discovery Introduction Cell surface proteins are essential regulators of cell communication, mediating …
The advent of artificial intelligence (AI) is fundamentally restructuring the landscape of protein drug discovery. Following breakthroughs in structural prediction …
Developing and manufacturing scheduled compounds requires not only technical excellence but also rigorous security, licensing, and regulatory oversight. Curia offers …
Steroids and hormonal therapies remain vital medicines for treating a wide range of conditions, yet their production continues to demand …
As drug pipelines shift toward increasingly potent molecules, safe containment and specialised handling have become essential to successful development and …